People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Reven Pharmaceuticals, Inc. | — | Pharmaceuticals | Series A | $14.8M | $137.5M | 2013 |
Michael B. Handley at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael B. Handley on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian B. Denomme | 1 | 1 |
| Peter B. Lange | 1 | 1 |
| Michael A. Volk | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.